Sickle Cell Disease Assn is categorized under Professional Organizations in Pensacola, FL and active since 2007.
Sickle Cell Disease Assn was established in 2007, and today employs 1 to 4, earning Unknown per year. This is a Professional Organizations business, which does work in the B2B market, and is classified as a Professional Organizations, under code number 8139100 by the NAICS.
If you are seeking more information, feel free to contact Debora Buskey at the company’s single location by writing to 514 North De Villiers St, Pensacola, Florida FL 32501 or by phoning (850) 434-6092. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Sickle Cell Disease Assn |
| Contact Person: | Debora Buskey |
| Address: | 514 North De Villiers St, Pensacola, Florida 32501 |
| Phone Number: | (850) 434-6092 |
| Website Address: | scdaescambia.org |
| Annual Revenue (USD): | Unknown |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Professional Organizations |
| SIC Code: | 8621 |
| NAICS Code: | 8139100 |
| Share This Business: |
Sickle Cell Disease Assn was started in 2007 to provide professional Professional Organizations under the SIC code 8621 and NAICS code 8139100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Debora Buskey for inquiries that concern Sickle Cell Disease Assn by calling the company number (850) 434-6092, as your correspondence is most welcome. Additionally, the physical location of the single location of Sickle Cell Disease Assn can be found at the coordinates 30.41786,-87.2232 as well as the street address 514 North De Villiers St in Pensacola, Florida 32501.
For its online presence, you may visit Sickle Cell Disease Assn’s website at scdaescambia.org and engage with its social media outlets through on Twitter and on Facebook.